Related by context. All words. (Click for frequent words.) 69 microcalcifications 66 mammographically 65 lung nodules 64 breast lesions 64 thyroid nodules 63 nodal metastasis 63 lymphomas leukemias 63 spontaneously regress 63 computerized tomography scans 62 hamartomas 62 thyroid carcinoma 62 lung nodule 62 extracapsular extension 62 Cystoscopy 62 malignant lesions 62 DCE MRI 62 atypical hyperplasia 61 spontaneous regression 61 colonic polyps 61 FDG-PET/CT 61 pulmonary nodules 61 computed tomography CT scans 61 fibrocystic disease 61 precursor lesions 60 calcifications 60 aerodigestive tract 60 mucinous 60 transrectal ultrasound 60 malignant ovarian 60 computed tomographic 60 malignant growths 60 biopsied tissue 60 Colon polyps 60 benign nodules 60 lymphatic mapping 60 mammographic 60 transabdominal 60 Sentinel Lymph Node Biopsy 60 needle biopsies 60 liver metastasis 60 transrectal ultrasound guided 60 Computed tomography 60 endometrial cancers 60 computed tomography scans 59 axillary dissection 59 positron emission tomography scans 59 ovarian malignancy 59 tumor histology 59 hamartoma 59 thyroglobulin 59 FDG PET scans 59 incidentalomas 59 Computed tomographic 59 colonoscopic 59 helical CT 59 pancreatic lung 59 fundus photography 59 precancers 59 BRCA deficient 59 cytologic 59 PET CT scans 58 computerized tomographic 58 computerized tomography scan 58 Lymph node 58 stratifying patients 58 oncogenic mutations 58 gastric cardia 58 BRCA2 carriers 58 gadolinium enhanced 58 cardiograms 58 subclinical disease 58 Seewaldt 58 cervical prostate 58 invasive lobular 58 noninvasive imaging 58 transesophageal echocardiography 58 neurofibroma 58 BRCA1 BRCA2 58 micrometastasis 58 choroidal melanoma 58 mammographic density 58 transvaginal sonography 58 histological diagnosis 58 color Doppler ultrasound 58 colorectal neoplasms 58 thyroid nodule 58 sonographic appearance 58 ultrasonographic 58 coronary CTA 58 molecular abnormalities 58 Fine needle aspiration 58 histopathologic findings 58 Histopathologic examination 58 core needle biopsy 58 chromosomal mutations 58 PAP smears 58 osteosarcomas 58 nodal metastases 58 CT perfusion 58 cisplatin resistant 58 precancer 58 Doppler ultrasound 58 PET positron emission tomography 58 detecting precancerous 58 breast endometrial 58 meningiomas 57 biopsies 57 hyperplastic polyps 57 pelvic ultrasound 57 Papillary 57 histopathologic examination 57 Coronary artery calcium 57 pre malignant lesions 57 pancreatic prostate 57 cervical lymph nodes 57 MR spectroscopy 57 malignant nodules 57 urine cytology 57 ductal cancer 57 adnexal masses 57 fibroadenomas 57 hormone refractory prostate 57 surgical biopsy 57 Positron emission tomography PET 57 lymph node removal 57 malignant prostate 57 arthrography 57 prostate cancer metastases 57 catheter angiography 57 pulmonary metastasis 57 contralateral breast 57 precancerous polyp 57 promoter hypermethylation 57 tumor subtype 57 uterine cervix 57 HER2 positive cancers 57 Cardiac catheterization 57 cancerous lumps 57 NSCLC tumors 57 Doppler echocardiography 57 sonographically 57 invasive biopsy 57 pathologic examination 57 adenoma detection 57 Virtual colonoscopy 57 excisional biopsy 57 fibrocystic 57 genomic alterations 57 surgical biopsies 57 Computed Tomography CT scans 57 carcinoid tumor 57 prostate abnormalities 57 DCIS lesions 57 lung pancreatic 57 CT coronary angiography 57 CT angiograms 57 proton MR spectroscopy 57 Vizilite 57 biochemical abnormalities 57 gene amplification 57 breast lumps 57 colon rectal 56 lesion localization 56 Doppler ultrasonography 56 tracer uptake 56 prostate cancer CaP 56 Coronary angiography 56 percutaneous biopsy 56 pulmonary angiography 56 ovarian colorectal 56 prostate carcinoma 56 computed tomography scanning 56 deCODE BreastCancer 56 clinically insignificant 56 hypervascular 56 pituitary adenomas 56 adenomatous polyps 56 scintigraphic 56 malignant tissue 56 Estrogen receptor positive 56 SLNB 56 prognostic biomarkers 56 breast biopsies 56 multidetector row 56 basal cell skin 56 extracolonic findings 56 axillary nodes 56 node metastases 56 #F FDG PET 56 premalignant lesions 56 histologic findings 56 colorectal gastric 56 hormone receptor negative 56 operable breast cancer 56 Waxenberg herself 56 brain lesions 56 metastatic lesions 56 adnexal mass 56 GIST tumors 56 ductal lavage 56 endoscopic ultrasonography 56 precancerous condition 56 Miglioretti 56 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 56 Hurthle cell 56 potentially cancerous polyps 56 chromosomal aberrations 56 Squamous cell 56 spinal metastases 56 ovarian endometrial 56 enhanced sonography 56 chest radiographs 56 bone scintigraphy 56 invasive carcinoma 56 somatic mutations 56 bladder prostate 56 colonography 56 gooey amyloid 56 hematopoietic cancers 56 transfusion syndrome 56 Birnbaum replies 56 T2 weighted images 56 lymph node metastases 56 benign lesion 56 supratentorial 56 prostate carcinomas 56 benign polyps 56 advanced adenomas 56 F FDG PET 56 Screening mammograms 56 sonographic findings 56 Sodickson 56 PCNSL 56 #F FDG 56 polyp detection 56 proximal colon 56 underwent coronary angiography 56 perineural invasion 56 T1 weighted 56 malignant polyps 56 Color Doppler 56 computed tomography angiography 56 gated SPECT 56 treating sarcoma testicular 56 lobular breast cancer 56 impair fertility 56 renal cell carcinomas 56 endometrial biopsy 56 prophylactic mastectomies 56 hormone receptor status 56 pathologic diagnosis 56 extracolonic 56 endometrioid 56 endobronchial 56 sentinel lymph node biopsy 55 Radical prostatectomy 55 histopathologic 55 chemo resistant 55 Prenatal diagnosis 55 unresectable tumors 55 haematuria 55 gastric carcinomas 55 breast uterine 55 Basal Cell 55 sentinel node 55 TRUS 55 polyps growths 55 nonhereditary 55 schwannomas 55 keloid 55 multislice 55 lymph node involvement 55 transthoracic 55 LHRH receptor positive 55 ophthalmoscopy 55 metastatic lymph nodes 55 undergo prostate biopsy 55 wedge resection 55 cancerous lesion 55 B7 H3 55 anaplastic 55 abdominal ultrasound 55 taxane therapy 55 radiographic findings 55 thermogram 55 nodular melanoma 55 chromosome aberrations 55 ovarian lung 55 invasive angiography 55 radionuclide imaging 55 lobular carcinomas 55 X rays ultrasounds 55 Adenomas 55 lobular carcinoma 55 squamous carcinoma 55 PCA3 scores 55 medically inoperable 55 Preoperative 55 visit www.rtanswers.org 55 obstructive coronary 55 endometrial breast 55 BRAF gene mutations 55 nonmelanoma skin cancers 55 fine needle aspiration 55 Diffusion Weighted 55 vestibular schwannomas 55 osteoid osteoma 55 urethral stricture 55 ovarian pancreatic 55 Prostate specific antigen 55 tumor subtypes 55 immunohistochemical analysis 55 hepatic lesions 55 hypointense 55 barium enemas 55 ductal carcinomas 55 prognostically 55 tumor biopsies 55 axillary node dissection 55 deCODE ProstateCancer TM 55 Adjuvant chemotherapy 55 advanced neoplasia 55 carotid artery ultrasounds 55 core needle biopsies 55 preoperative staging 55 biopsying 55 metastatic basal cell 55 neuroendocrine carcinoma 55 atypical lobular hyperplasia 55 locoregional recurrence 55 pheochromocytomas 55 DNA methylation patterns 55 detecting polyps 55 Tomosynthesis 55 FGFR2 gene 55 CT angiography 55 ependymomas 55 chest radiography 55 biopsy specimen 55 dermoscopy 55 FDG uptake 55 breast MRIs 55 nondiagnostic 55 ductal adenocarcinoma 55 ASCUS 55 needle aspiration 55 TOP2A 55 Magnetic resonance 55 perfusion imaging 55 clinicopathological 55 Chest x rays 55 lymph node metastasis 55 Histologically 55 Breast MRIs 55 curability 55 testicular cancers 55 Diffusion weighted 55 EBUS 54 endometrial carcinoma 54 beta1 integrin 54 prostate bladder 54 fibroadenoma 54 HER2 expression 54 benign ovarian 54 bone marrow biopsies 54 CT angiogram 54 tumor excision 54 tumors 54 mammographic breast density 54 cystoscopic 54 nonmelanoma 54 Prostatitis 54 leiomyomas 54 breast ovary 54 FDG PET 54 nuchal 54 histologic examination 54 serrated polyps 54 seminal vesicle invasion 54 neurosensory 54 hematologic malignancy 54 Bone density 54 x rays MRIs 54 debulking surgery 54 functional neuroimaging 54 radiographic examinations 54 Sentinel node biopsy 54 cervical lymph node 54 Paraffin Embedded FFPE 54 chemosensitivity 54 pre cancerous growths 54 pancreatic cysts 54 rhabdoid 54 parathyroid 54 endoscopic ultrasound EUS 54 diffusion tensor 54 Oncotype 54 arteriography 54 #F fluorodeoxyglucose 54 Abdominal ultrasound 54 precancerous tumors 54 malignant brain 54 cortical atrophy 54 epithelial tumors 54 carotid plaque 54 bony metastases 54 peritoneal carcinomatosis 54 lymph node biopsies 54 intravital 54 sentinel nodes 54 prophylactic cranial irradiation 54 spiral computed tomography 54 cancerous polyps 54 angiographically 54 diverticular 54 multidetector CT 54 fine needle aspirate 54 methylation markers 54 HER2 positive tumors 54 atypical nevi 54 anastomotic devices 54 called elastography distinguished 54 prognostic significance 54 Breast Specific 54 extracranial 54 Sonographic 54 HER2 positive breast 54 hypertensive retinopathy 54 ACE inhibitors dilate 54 cryosurgery freezing 54 VATS lobectomy 54 lymphovascular invasion 54 CT angiography CTA 54 lymphatic tissue 54 dosimetric 54 densest breasts 54 Basal cell 54 lung lesions 54 Fibroid tumors 54 x ray computed tomography 54 gene rearrangements 54 BRCA mutation carriers 54 lobular cancer 54 renal carcinoma 54 denser breasts 54 pelvic malignancies 54 overexpress HER2 54 differentiated thyroid 54 breast cancer subtypes 54 color Doppler 54 preoperative diagnosis 54 tomography scans 54 HER2 amplification 54 antiphospholipid antibodies 54 benign moles 54 carotid stenosis 54 angiography CTA 54 coronary angiogram 54 hyperintense 54 colo rectal 54 carotid artery blockage 54 renal tumors 54 perfusion CT 54 Ultrasound scans 54 leiomyoma 54 colorectal polyps 54 color Doppler sonography 54 pancreatic adenocarcinoma 54 stereotactic radiotherapy 54 BRCA2 mutation carriers 54 morphologic 54 lung metastasis 54 intact parathyroid hormone 54 diffusion MRI 54 endorectal coil 54 anal lesions 54 cervix uteri 54 breast asymmetry 54 digital rectal examination 54 noncancerous cells 54 malignant pheochromocytoma 54 sputum cytology 54 gastric carcinoma 54 SPINK1 54 coronary computed tomography 54 melanoma lesions 54 biopsy 54 perioperative complications 54 colorectal lung 54 underwent resection 54 vascular abnormalities 54 SPECT CT imaging 54 Sentinel lymph node 54 benign uterine 54 oncologic outcomes 54 molecular subtypes 54 Multidetector CT 54 recurrent ovarian 54 pre cancerous polyps 54 underarm lymph nodes 54 perfusion abnormalities 54 VCUG 54 computed tomographic CT 54 CT computerized tomography 54 bladder tumors 54 myxoma 54 hyperacute 54 histological subtype 54 squamous cell lung cancer 54 normal karyotype 54 sentinel lymph nodes 54 sonographic 54 miRNA profiling 54 multislice CT 53 carcinomatosis 53 EBUS FNA 53 plexiform 53 axillary lymph nodes 53 invasive lobular carcinoma 53 invasive biopsies 53 abdominal computed tomography 53 polypoid 53 Elevated PSA 53 Computerized tomography 53 near infrared fluorescence 53 abnormal moles 53 microbleeds 53 Medicsight ColonCAD 53 fibroma 53 carotid plaques 53 Ultrasonography 53 laterality 53 axillary node 53 nonmetastatic 53 anti angiogenic drugs 53 CIN2 + 53 colorectum 53 aneuploid cells 53 echogenic 53 Mohs micrographic surgery 53 painless lump 53 pre cancerous lesion 53 treating neuropathic pain 53 sonographically guided 53 nodular lesions 53 noncancerous 53 unneeded biopsies 53 photoacoustic 53 methylation profiling 53 sentinel node biopsy 53 peritoneal cancer 53 dysplastic lesions caused 53 cCTA 53 peri implant 53 cardiac perfusion 53 densitometry 53 histological examination 53 fetal aneuploidy 53 electrophysiologic 53 poorer prognosis 53 Functional magnetic resonance 53 duplex ultrasonography 53 diagnose Alzheimer disease 53 cancerous moles 53 recurrent bladder 53 DCIS ductal carcinoma 53 digital subtraction angiography 53 SUVmax 53 testicular tumors 53 Prognostic factors 53 transesophageal 53 seminomas 53 ovarian colon 53 echogenic foci 53 deCODE BreastCancer TM 53 severe hepatic dysfunction 53 ipRGCs 53 positron emission 53 surgically resectable 53 Doppler imaging 53 PET scanning 53 mediastinal lymph nodes 53 Breast Specific Gamma 53 serous ovarian cancer 53 diffusion weighted 53 Mammotome MR 53 lipomas 53 conventional angiography 53 Multivariate analyzes 53 esophagogastric junction 53 detect precancerous lesions 53 postoperative complication 53 hyperplastic 53 abnormal vascularization angiogenesis 53 gastroscopy 53 carcinoid 53 invasive ductal carcinoma 53 gamma imaging 53 Magnetic resonance imaging 53 bladder ovarian 53 sonographic evaluation 53 CIN3 53 SPECT PET 53 florbetaben 53 Positron emission tomography 53 mutated BRAF gene 53 pleomorphic 53 intracranial stenosis 53 spiral CT scan 53 ultrasonographic examination 53 papillary carcinoma 53 lumbar disk herniation 53 computed tomographic scans 53 progesterone receptor negative 53 osteoid 53 abdominal ultrasounds 53 adrenocortical cancer 53 chorionic villi 53 noncancer 53 benign growths 53 Ultrasonographic 53 retroperitoneal 53 colorectal adenocarcinoma 53 tortuosity 53 transcranial Doppler 53 intestinal polyps 53 ultrasound elastography 53 pT2 53 intima media thickness 53 basal cell cancers 53 ventilation perfusion 53 clinicopathologic 53 hyperintensity 53 electron beam computed tomography 53 benign lesions 53 prognostic indicators 53 bone bruise Bettis 53 PCA3 gene 53 immunohistochemical staining 53 genomic rearrangements 53 cystoscopy 53 x ray mammography 53 pigmented lesion 53 localized renal 53 artery embolization 53 Her2 positive 53 DXA scan 53 bile duct cancers 53 diagnostic biomarker 53 lung tumors 53 pelvic lymph nodes 53 HER2 overexpression 53 breast carcinoma 53 radical prostatectomy RP 53 papillary 53 left ventricular diastolic 53 atypical ductal hyperplasia 53 Metastases 53 EUS FNA 53 benign prostatic hyperplasia enlarged 53 cervical biopsies 53 pCR 53 mammary duct 53 microRNA expression 53 prognostic biomarker 53 localized prostate 53 malignant lymph nodes 53 KRAS oncogene 53 unsightly veins 53 colon ovarian 53 telomerase inhibition 53 clefting 53 granulosa cell 53 Mammographic 53 colon prostate 53 renal artery stenosis 53 chest x ray 53 amyloid deposition 53 endocervical 53 perfusion defects 53 breast tumors 53 mammograms Hruska 53 skeletal metastases 53 mesenteric 53 benign neoplasms 53 Angiograms 53 PET imaging 53 basal cell carcinoma squamous 53 PET CT imaging 53 contralateral breast cancer 53 Biopsies 53 metastatic lesion 53 conventional colonoscopy 53 FGFs 53 SoftView 53 RNFL thickness 53 glial tumors 53 pelvic radiotherapy 53 thymectomy 53 distal colon 53 malignant tissues 53 cardiac computed tomography 52 Li Fraumeni 52 pCLE 52 completely resected 52 melanocytic 52 prostate cancer PCa 52 PiB PET 52 pituitary adenoma 52 Genetic mutation 52 familial clustering 52 angio 52 suspicious moles 52 PET CT fusion 52 underlying pathophysiology 52 microsatellite instability 52 invasive carcinomas 52 karyotyping 52 bioluminescent imaging 52 ischemic lesions 52 UVB induced 52 Velculescu 52 bowel polyps 52 computed tomographic scan 52 KRAS mutation 52 abnormalities 52 urolithiasis 52 polypectomy 52 CT pulmonary angiography 52 estrogen receptor progesterone receptor 52 cervical precancers 52 curable cancers 52 cardiac troponin 52 TMEM density 52 gastric corpus 52 histopathological 52 detect polyps 52 RT PCR assay 52 troponin T 52 malignant phenotype 52 immunostaining 52 transrectal ultrasonography 52 iPS derived 52 Hormone receptor 52 fibroids endometriosis 52 venography 52 Infrared spectroscopy 52 enhanced MR angiography 52 Immunohistochemical 52 grade gliomas 52 colonoscopy sigmoidoscopy 52 mammogram ultrasound 52 Circulating tumor cells 52 malignant lesion 52 FDG PET CT 52 conformal radiotherapy 52 CSF biomarkers 52 tomographic images 52 K ras mutations 52 invasive coronary angiography 52 FFR measurements 52 Genetic variants 52 postoperative pathology 52 morphometry 52 esophagus colon 52 EGFR mutation positive 52 mutated K ras 52 GISTs 52 T1 weighted images 52 ovarian cervical 52 MDCT angiography 52 Getzenberg 52 dysplastic nevi 52 keratectomy 52 cytologically 52 BRCA carriers 52 cancerous nodules 52 necrotic core 52 metaplasia 52 AGTR1 52 T1a 52 varicoceles 52 arterial calcification 52 colon pancreatic 52 pancreatic endocrine 52 colorectal ovarian 52 lymphoproliferative disorders 52 acetabular fractures 52 anatomic abnormalities 52 computed tomography SPECT 52 Garzotto 52 abnormal pap smears 52 dental x rays 52 abnormal growths 52 FDG PET imaging 52 precancerous colon growths 52 luminal progenitor cells 52 tumor metastases 52 fluorodeoxyglucose positron emission tomography 52 lens opacities 52 Scintigraphy 52 molar pregnancy 52 Menopausal hormone therapy 52 optic nerve sheath 52 electron beam tomography 52 adenomatous polyp 52 resect 52 adenoma 52 Subgroup analyzes 52 preoperative chemotherapy 52 computed tomography CT angiography 52 pigmented skin lesions 52 grade squamous intraepithelial 52 axilla 52 biochemical recurrence 52 preoperative PSA 52 KRAS mutated 52 MiCK assay 52 MR arthrography 52 epididymal 52 chlamydial infection 52 spirometric 52 benign biliary strictures 52 ovarian tumors 52 MRIs magnetic resonance 52 abnormal cytology 52 papillary thyroid carcinoma 52 da mage 52 carotid artery thickness 52 adjuvant therapies 52 cystic mass 52 refractory colorectal cancer 52 brain perfusion scans 52 Elastography 52 optical coherence tomography 52 tissue biopsies 52 bladder cancers 52 Hilakivi Clarke 52 PSADT 52 Herceptin monoclonal antibody 52 Molecular imaging 52 abnormal mammograms 52 seminoma 52 pulsed Doppler 52 bullous 52 zebrafish larvae 52 biopsy needle 52 genetic aberrations 52 biliary tract cancers 52 pulmonary metastases 52 CT scans MRIs 52 nonmetastatic breast cancer 52 tumoral 52 magnetic resonance angiography 52 primitive neuroectodermal tumors 52 GBA mutations 52 metastatic pancreatic 52 miRNA biomarkers 52 metastatic colorectal 52 neoplasias 52 Dr. Dean Toriumi 52 basilar 52 Keloids 52 Sigmoidoscopy 52 lung biopsies 52 precancerous cervical 52 BRAF V#E mutation 52 ductal breast cancer 52 attentional blink 52 esophagogastric 52 lichen planus 52 abnormal Pap smear 52 pretest probability 52 intraductal 52 X ray computed tomography 52 Optical coherence tomography 52 prostate radical prostatectomy 52 neurofibromas 52 cytologic examination 52 HG PIN 52 lactate dehydrogenase LDH 52 gastrointestinal GI cancers 52 Screening Trial DMIST 52 highly vascularized 52 parenchymal 52 ovarian breast 52 carcinoids 52 imaging MRI 52 troponins 52 radiographic imaging 52 postoperative delirium 52 pAkt 52 mammary cancers 52 neuroblastoma tumor 52 chromosomal rearrangement 52 micrometastases 52 PET CT scan 52 hematological relapse 52 androgen ablation 52 coronary CT angiography 52 intraoperative complications 52 Benign breast 52 immunohistochemical 52 TRUS biopsy 52 urothelial carcinoma 52 Microscopic examination 52 IDH1 mutation 52 colon pancreas 52 abnormal p# 52 needle biopsy 52 hormonally responsive 52 acute aortic dissection 52 SELDI TOF MS 52 EKG electrocardiogram 52 spectroscopic technique 51 neovasculature 51 endometrial ovarian 51 bone density measurements 51 ductal lobular 51 tumor xenografts 51 EGFR pathway 51 castration resistant hormone refractory 51 tumor perfusion 51 histologic subtype 51 bone marrow biopsy 51 noncardiac 51 uterine tumors 51 antiangiogenic therapy 51 calculi 51 hypoechoic 51 x rays CT scans 51 nanoprobe 51 biliary obstruction 51 Skin lesions 51 NMIBC 51 interventional neuroradiologists 51 colon resection 51 malignant pancreatic 51 intensity modulated 51 painless ultrasound 51 conditional logistic regression 51 tomography imaging 51 colorectal cancer CRC 51 advanced malignant hepatic 51 Histologic 51 PET scan 51 prostate pancreatic 51 FDDNP PET 51 melanocytic lesions 51 Basal cell carcinomas 51 condition Arrhythmogenic Right 51 colorectal polyp 51 neurologic complications 51 sinonasal 51 cranial radiation 51 Sentinel Lymph Node 51 Gabriel Lopez Berestein 51 Vunjak Novakovic 51 diagnostic mammogram 51 radiotherapy RT 51 prognostic markers 51 gynecologic malignancy 51 esophageal tumors 51 Neugut 51 progesterone receptor PR 51 ovarian carcinoma 51 uveal melanoma 51 paragangliomas 51 computerized axial tomography 51 histopathological examination 51 PAP smear 51 armpit lymph nodes 51 pancreatic colon 51 #.#ng/ml 51 submucosal 51 T1c 51 anatomical landmarks 51 Dr Zorbas 51 esophageal gastric 51 radiosensitive 51 para aortic 51 postoperative chemotherapy 51 MSCT 51 EGF receptors 51 cardiac CT angiography 51 extracapsular 51 parotid salivary gland 51 hilar 51 incisional biopsy 51 neuro imaging 51 seborrheic keratoses 51 flow cytometric 51 sentinel node biopsies 51 enlarged ventricles 51 epigenetic markers 51 polycystic ovarian disease 51 genetic rearrangements 51 x ray angiography 51 transesophageal echocardiogram